2019年5月14日 · The Acorn AI products include Value Discovery Engine to make better go/no-go decisions; Intelligent Trials to improve study success and speed; Integrated Evidence to help demonstrate value to regulators, payors, providers and patients; and Connected Devices to integrate the new generation of medical devices within the digital healthcare ecosystem.

中国上海——达索系统 全资子公司 Medidata近日宣布Medidata Acorn AI Synthetic Control Arm (SCA, 合成对照组)获本年度人工智能突破奖（AI Breakthrough Award）“最佳医疗类人工智能解决方案”的称号。

Unlock the potential of cross-sponsor clinical trial data with Medidata’s proprietary machine learning (ML) and AI algorithms and advanced analytics, including generative AI and predictive modeling.

Acorn AI is a leading AI company dedicated to Life Sciences. Acorn AI is built on top of the Medidata platform and comprises the industry’s largest structured, standardized clinical data repository of more than 20,000 clinical trials from 1400+ customers with 6M patients and 22K healthcare facilities with investigators across 94 countries.

Acorn: The #1 Book Summary & Podcast App! Unlock key insights from top books and save inspiring quotes and ideas—all in one powerful app. Learn smarter, grow faster, anytime, anywhere!

2020年8月19日 · Acorn AI’s advanced analytics answers the most important questions in R&D and commercialization including accelerating breakthrough innovation, optimizing study execution and...

Acorn AI™的解决方案由Medidata提供核心临床数据技术支持,拥有结构化、标准化、业界最大之一的临床试验数据库,内含17,000多项临床试验和480万患者数据,与现实数据、转化数据及其他数据库互通互联。

2021年8月24日 · 英派药业与法国达索系统全资子公司Medidata宣布达成合作，Medidata旗下Acorn AI Study Feasibility研究可行性解决方案首次应用于在华制药企业，满足大规模国际多中心临床研究的需求，助力推进临床试验的进程。

2019年4月11日 · Medidata's new venture, Acorn AI, builds on a combination of deep life science pedigree, proprietary data sets, and AI methodologies to help life science customers reimagine their operating...

Medidata Acorn AI provides unparalleled clinical data, advanced analytics, and industry expertise for pharmaceutical, biotech, and medical device leaders, to help reimagine what is possible, uncover breakthrough insights, make confident decisions, and pursue continuous innovation.